Compare TRS & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRS | ATEC |
|---|---|---|
| Founded | 1986 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2004 | 2006 |
| Metric | TRS | ATEC |
|---|---|---|
| Price | $39.29 | $9.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $41.50 | $22.00 |
| AVG Volume (30 Days) | 347.0K | ★ 1.5M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | ★ 400.00 | 15.04 |
| EPS | ★ 21.96 | N/A |
| Revenue | ★ $645,720,000.00 | $101,739,000.00 |
| Revenue This Year | $5.42 | $18.97 |
| Revenue Next Year | $4.27 | $16.70 |
| P/E Ratio | $1.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.43 | $6.82 |
| 52 Week High | $45.43 | $23.29 |
| Indicator | TRS | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 47.12 |
| Support Level | $38.42 | $8.99 |
| Resistance Level | $39.33 | $9.84 |
| Average True Range (ATR) | 0.99 | 0.39 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 49.85 | 18.65 |
TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.